List view / Grid view
The toxicity and antiviral properties of 24 low-molecular-weight artificial RNases (artRNases) including peptides, peptidomimetics, N-alkyl-substituted 1,4-diazabicyclo[2.2.2]octane (DABCO) and a silver (I) complex with cystine were analysed for viruses containing single-stranded and double-stranded genomic RNA (the tick-borne encephalitis virus; TBEV and the influenza virus, respectively) in vitro and in vivo by…
1 June 2016 | By Victoria White, Digital Content Producer
Scientists have created a drug candidate that attacks and neutralises the RNA structure that causes spinocerebellar ataxia type 10 (SCA10)...
Neglected tropical diseases pose a significant threat to public health and affect nearly one billion people in tropical and sub-tropical regions throughout the world. There is a pressing need to identify new therapeutics for NTDs and many developed nations are participating in drug discovery efforts...
8 February 2016 | By SMi Group
SMi will open its doors to host RNA Therapeutics 2016 in just 1 week on 15th and 16th February in Central London...
2 February 2016 | By Victoria White
A team of scientists from Bath, Cambridge and the USA has identified a piece of non-coding RNA that stops cells turning cancerous...
11 January 2016 | By Victoria White
mRNA-based therapies are an innovative treatment approach that enables the body to produce therapeutic protein in vivo, opening up new treatment options for a wide range of diseases...
13 October 2015 | By Victoria White
An RNA editing technique called "exon skipping" has demonstrated preliminary success in treating Limb Girdle Muscular Dystrophy Type 2C in a new study...
17 September 2015 | By Victoria White
The new technique could be used to explore genetic mechanisms of resistance in the field of infectious disease and lead to new therapies...
24 July 2015 | By Victoria White
UCLA scientists have discovered a microRNA-214 inhibitor that has the ability to suppress the development of ulcerative colitis...
2 July 2015 | By Victoria White
Scientists from The Scripps Research Institute have found that microRNAs plays surprisingly different roles in the formation of memory in animal models...
30 June 2015 | By Victoria White
Scientists have unravelled a key process in the bacterium that causes TB, potentially paving the way for new antibiotics to fight the disease...
10 June 2015 | By Victoria White
Researchers have discovered that certain microRNAs are also asymmetrically distributed within cells and may contribute as cell fate determinants...
20 April 2015 | By Victoria White
Takeda, Keio University and Niigata University are to collaborate to research disease-related RNA-binding proteins, possibly leading to new treatments...
24 March 2015 | By Victoria White
Rigontec, a company developing RNA-based immunotherapeutics, today announces it has raised €4.8 million in a second closing of its Series A financing round...
5 August 2014 | By Roche
Roche announced that it has agreed to acquire Santaris Pharma, a privately held biopharmaceutical company based near Copenhagen, Denmark...
